Compare Pfizer with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DIVIS LABORATORIES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DIVIS LABORATORIES PFIZER/
DIVIS LABORATORIES
 
P/E (TTM) x 35.8 35.4 101.3% View Chart
P/BV x 6.1 6.6 91.9% View Chart
Dividend Yield % 0.6 0.9 60.9%  

Financials

 PFIZER   DIVIS LABORATORIES
EQUITY SHARE DATA
    PFIZER
Mar-19
DIVIS LABORATORIES
Mar-19
PFIZER/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,8401,639 234.2%   
Low Rs2,0801,115 186.5%   
Sales per share (Unadj.) Rs455.0186.3 244.2%  
Earnings per share (Unadj.) Rs93.851.0 184.0%  
Cash flow per share (Unadj.) Rs109.457.3 190.8%  
Dividends per share (Unadj.) Rs22.5016.00 140.6%  
Dividend yield (eoy) %0.81.2 65.4%  
Book value per share (Unadj.) Rs658.2261.8 251.4%  
Shares outstanding (eoy) m45.75265.47 17.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.57.4 88.0%   
Avg P/E ratio x31.627.0 116.8%  
P/CF ratio (eoy) x27.124.0 112.6%  
Price / Book Value ratio x4.55.3 85.5%  
Dividend payout %24.031.4 76.4%   
Avg Mkt Cap Rs m135,420365,592 37.0%   
No. of employees `0002.611.8 22.2%   
Total wages/salary Rs m3,2385,423 59.7%   
Avg. sales/employee Rs Th7,911.44,175.1 189.5%   
Avg. wages/employee Rs Th1,230.9457.7 268.9%   
Avg. net profit/employee Rs Th1,630.71,141.8 142.8%   
INCOME DATA
Net Sales Rs m20,81549,463 42.1%  
Other income Rs m1,6741,556 107.6%   
Total revenues Rs m22,48951,019 44.1%   
Gross profit Rs m5,71218,718 30.5%  
Depreciation Rs m7141,689 42.3%   
Interest Rs m7335 208.3%   
Profit before tax Rs m6,59918,551 35.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3095,023 46.0%   
Profit after tax Rs m4,29113,527 31.7%  
Gross profit margin %27.437.8 72.5%  
Effective tax rate %35.027.1 129.2%   
Net profit margin %20.627.3 75.4%  
BALANCE SHEET DATA
Current assets Rs m27,16746,501 58.4%   
Current liabilities Rs m8,9178,468 105.3%   
Net working cap to sales %87.776.9 114.0%  
Current ratio x3.05.5 55.5%  
Inventory Days Days68131 51.8%  
Debtors Days Days3086 35.1%  
Net fixed assets Rs m8,86225,797 34.4%   
Share capital Rs m458531 86.2%   
"Free" reserves Rs m29,65668,962 43.0%   
Net worth Rs m30,11369,493 43.3%   
Long term debt Rs m250-   
Total assets Rs m39,40080,383 49.0%  
Interest coverage x91.5531.0 17.2%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.6 85.9%   
Return on assets %11.116.9 65.6%  
Return on equity %14.219.5 73.2%  
Return on capital %22.126.7 82.8%  
Exports to sales %00-   
Imports to sales %024.6 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA12,187 0.0%   
Fx inflow Rs m42841,238 1.0%   
Fx outflow Rs m78612,405 6.3%   
Net fx Rs m-35828,833 -1.2%   
CASH FLOW
From Operations Rs m9789,543 10.2%  
From Investments Rs m351-6,854 -5.1%  
From Financial Activity Rs m-1,099-2,459 44.7%  
Net Cashflow Rs m231230 100.5%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 11.8 63.6%  
FIIs % 4.9 19.0 25.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.2 137.8%  
Shareholders   85,207 31,796 268.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   BIOCON   WOCKHARDT  VENUS REMEDIES  PANACEA BIOTECH  FDC LTD.  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Telecom and Energy Stocks Gain(09:30 am)

Asian share markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.2% while the Hang Seng is up 1.1%.

Related Views on News

DIVIS LABORATORIES Announces Quarterly Results (2QFY20); Net Profit Down 10.3% (Quarterly Result Update)

Nov 11, 2019 | Updated on Nov 11, 2019

For the quarter ended September 2019, DIVIS LABORATORIES has posted a net profit of Rs 4 bn (down 10.3% YoY). Sales on the other hand came in at Rs 14 bn (up 12.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Nov 18, 2019 11:45 AM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS